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Abstract
Oral immunotherapy (OIT) is a promising therapeutic approach for treating food allergy. 1 
The treatment with heated ovomucoid-depleted egg white (HOM`EW) in egg allergic 2 
patients is noteworthy, however, OIT protocols are still experimental and a better 3 
knowledge of the underlying mechanism is required. The objective of this work was to 4 
investigate the immunomodulatory effects of HOM’EW and characterize the underlying 5 
mechanism in a Balb/c mouse model of egg allergy. Mice were sensitized with EW and 6 
treated with HOM’EW. Post treatment, mice were challenged with EW and euthanized for 7 
collecting blood and spleen. Markers of allergic clinical outcomes were measured as 8 
histamine concentration, serum antibody activity and cytokine production from cultured 9 
splenocytes. Digestibility of HOM’EW was assessed mimicking physiological conditions 10 
in vitro. The HOM’EW demonstrated high digestibility. The treatment induced a marked 11 
increase of Th1/Th2 ratio in the high dose treatment group. Treated mice had significantly 12 
less histamine, EW-specific IgE and IL-4 and more of IFN-γ and IL-10. This study 13 
concludes mechanisms involved in successful tolerance induction with OIT using 14 
HOM’EW and allows understanding of the vital role of surrogate allergy markers involved 15 
in immune-modulation. 16 
 17 
Keywords: food allergy, egg white, ovomucoid, Balb/c mice, oral immunotherapy. 18 
 19 
 20 
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Introduction 21 
Food allergies are recognized as a global medical problem that affects more than 25% of 22 
the population in industrialized countries (1) and accounts for one third to one half of 23 
anaphylaxis cases worldwide (2). Prevalence of food allergies is on the rise and a 24 
concerning increase of 18% has been reported in the USA from 1997 to 2007 (3). Recently 25 
it has been reported that estimates are about 5% in children and 3% to 4% among adults (4). 26 
Egg allergy is the second most common cause of food allergies in children (5) and four 27 
major allergens in the egg white [ovomucoid (OM or Gal d 1), ovalbumin (OVA or Gal d 28 
2), ovotransferrin (OVT or Gal d 3) and lysozyme (LYS or Gal d 4)] contribute to induction 29 
of allergy (6). Among the four, OM is considered immunodominant (7) due to its stability 30 
to heat treatment (8) and enzymatic digestion (9) and ability to retain IgE binding epitopes 31 
after in vitro digestion (10). 32 
At present, the main treatment for egg allergic patients is based on food avoidance; 33 
however, this poses a challenge due to the omnipresence of eggs in a wide range of food 34 
(11). Furthermore, it has been shown that avoidance could lead to a lower reactivity 35 
threshold in human subjects (12). For these reasons, a therapeutic approach seems more 36 
appropriate for the treatment of egg allergies. Oral immunotherapy (OIT)  is one of the 37 
most studied therapeutic approaches and encouraging results have been recently reported 38 
both in mice (13) and human (14). Nevertheless oral tolerance induction protocols to food 39 
allergens are still ongoing and are only experimental because there are remaining questions 40 
that need to be answered prior to exploring OIT as a treatment module such as to identify 41 
the severity and type of food allergy response to treatment, if OIT leads to desensitization 42 
or oral tolerance, if oral tolerance occurs naturally or is induced by treatment, the optimal 43 
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dose and duration, the degree of protection, and establishment of an adequate dose and if a 44 
maintenance dose is necessary, etc. Hence appropriate conditions for allergen preparation, 45 
treatment protocols and outcomes for OIT need to be standardized. Although few common 46 
facts related to successful OIT have been described such as reduction in specific IgE 47 
activity, induction of IgG4/IgG2a, altered T-cell cytokine balance (shift Th2 to Th1 type 48 
response) and T-cell anergy (15); the overall mechanism is not completely understood, for 49 
example the role of specific IgA exerted at mucosal level (16), or the controversial role of 50 
specific IgG and its respective isotype subclasses (17). 51 
With regards to EW OIT, the use of heated EW formulas has always been a common 52 
choice and is frequently reported (18). The treatment with heated ovomucoid-depleted egg 53 
white (HOM’EW) is especially notable. The HOM’EW can be used in approximately 95% 54 
of egg allergic patients because of its hypoallergenic character and has been demonstrated 55 
to be safe (19). Furthermore the effectiveness of HOM’EW in EW allergic patients has 56 
been proven recently (18) but the underlying mechanism still remains unclear. Reliable 57 
protocols for OIT are underway and more light is being shed on the mechanisms involved 58 
in OIT (14, 20-22). 59 
With this background, our objective was to study the immunomodulatory effect of 60 
HOM’EW in a Balb/c mouse model of egg allergy to reach a better understanding of the 61 
mechanisms involved by which HOM’EW desensitizes and may induce oral tolerance. 62 
 63 
Materials and methods 64 
Preparation of HOM’EW 65 
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HOM´EW was prepared as previously described (19) with slight variations. In brief, egg 66 
white was separated and diluted (1:10; v/v) with milli-Q water and sieved by a metallic 67 
strainer and the pH was adjusted to 5. The sample was heated at 95ºC for 30 min. After heat 68 
treatment, the sample was centrifuged at 7000 g at room temperature (RT) for 30 min. 69 
Since OM does not coagulate by heating, the OM was retained in the supernatant while the 70 
precipitate contained the HOM’EW. The precipitate was confirmed by western blotting 71 
(Figure 1) to ensure that the sample was composed of HOM’EW. The sample thus obtained 72 
was freeze dried and stored at -30ºC for further use. 73 
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) 74 
The SDS-PAGE electrophoresis was performed according to the method of Laemmli (23). 75 
Samples (40µg/well) were dissolved in sample buffer in the presence of 5% (v/v) β-76 
mercaptoethanol, heated for 5 min at 95ºC and run on  4-12% Criterion XT gels (Bio-Rad 77 
Laboratories, Hercules, CA). Gels were stained using Coomassie G-250 (Bio-Rad) and 78 
destained using a 40% methanol, 7% acetic acid solution. 79 
Reverse phase high-performance liquid chromatography (RP-HPLC) 80 
The RP-HPLC analysis was performed using a Waters 600 HPLC instrument (Waters, 81 
Milford, MA) and a 250 mm X 4.6 mm Widepore C18 column (Bio-Rad, Richmond, CA). 82 
Operating conditions were as follows: column at RT; flow rate at 1 mL/min; injection 83 
volume at, 60 µL; solvent A (0.37 mL/L TFA in Milli-Q water); and solvent B (0.27 mL/L 84 
TFA in HPLC grade acetonitrile). A linear gradient of solvent B in A, from 0 to 60% in 60 85 
min, followed by 60% B for 30 min, was used. Absorbance was recorded at 220 nm with a 86 
Waters 2487 λ dual detector. The software Empower 2000 system data (Waters) was used. 87 
Western Blotting 88 
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Following SDS-PAGE electrophoresis, the proteins (20µg/well) were transferred onto a 89 
0.45 µm nitrocellulose membrane (Bio-Rad) using a semi-dry transfer cell (Bio-Rad). The  90 
membrane was blocked at room temperature for 2 h with 1% casein dissolved in 1X TBS 91 
(25 mM Tris-HCl, 0.15 M NaCl, pH 7.4; blocking buffer) and then incubated at 4°C 92 
overnight with rabbit anti-OM IgG antibody with horseradish peroxidase (HPR) (Immune 93 
Systems Ltd., ISL, Paignton, U.K.) diluted  1:25000  in blocking buffer. Following 94 
overnight incubation, the membrane was washed (6 × 5 min) in 1 × TBS with 0.05% 95 
Tween-20. Eventually the blots were visualized using the ECL prime western blotting 96 
detection reagent (GE Heathcare, Buckinghamshire, UK).  97 
Gastric and duodenal digestion 98 
 99 
Digestibility of EW and HOM’EW were demonstrated  using an in vitro model system in 100 
two steps, which mimics gastric and duodenal digestion in vivo (24). Both EW and 101 
HOM‘EW were subjected to in vitro gastric digestion at 5.7 mg/mL final concentration. In 102 
brief, the digestions were performed in simulated gastric fluid (SGF, 35 mM NaCl) at pH  103 
2.0, for 60 min at 37ºC, with porcine pepsin (EC 3.4.23.1, 3210 U/mg protein, Sigma-104 
Aldrich) at an enzyme: substrate ratio (E:S) of 1:20, w/w (172 U/mg). Aliquots were taken 105 
at 0, 30 and 60 min of incubation and adjusting the pH to 7 with 1 M NaHCO3 stopped the 106 
reaction. Duodenal digestions were performed by using the 60 min gastric digests adjusted 107 
to pH 7, as described above, with the addition of: 1 M CaCl2, 0.25 M Bis-Tris pH 6.5 and a 108 
0.125 M bile salt mixture containing equimolar quantities of sodium cholate and sodium 109 
deoxycholate (Sigma-Aldrich). After incubation at 37 ºC for 15 min, pancreatin (Sigma-110 
Aldrich) was added at an enzyme: substrate ratio of 1:25, w/w. The final composition of the 111 
mixture  was: 4.27 mg/mL of EW or HOM’EW, 6.15 mM of each bile salt, 20.3 mM Bis-112 
Tris, 7.6 mM CaCl2; and pancreatin (enzyme:substrate ratio 1:25 w/w). Aliquots were taken 113 
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after 60 min of gastric digestion and 30 min of duodenal digestion. Duplicate digestions 114 
were conducted for each condition.  115 
Animal Sensitization and Challenge 116 
Female Balb/c mice (n=40) were purchased from Charles River Laboratories (Montreal, 117 
QC, Canada) at 6–8 weeks of age and randomly divided into four groups (n=10/group). All 118 
animals were housed in the campus animal facility at the University of Guelph under an 119 
egg-free diet [Teklad global diet, 14% protein (wheat and corn) and 3.5% fat] in a 12 h 120 
lighting cycle. Food and water were available ad libitum. All procedures were performed in 121 
accordance with the guidelines established by the Canadian Council of Animal Care 122 
(CCAC) and approved by the Animal Care Committee at the University of Guelph. As 123 
shown in Figure 2, following a 1-week acclimatization period, positive and treatment 124 
groups were sensitized with EW (5mg/mouse) and 10 µg of cholera toxin (CT) (List 125 
Biologicals, Denver, CO, USA) by oral gavage twice a week for a duration of 4 weeks. 126 
After the sensitization phase, EW-specific IgE activity was determined by ELISA to ensure 127 
that the positive and treatment groups were sensitized. Post the sensitization period 128 
HOM’EW was orally administered to the treatment groups thrice a week for six weeks in 129 
two different doses: 2.5 mg (high dose group) and 1.0 mg (low dose group). The positive 130 
and the negative groups received PBS. All mice were challenged on week 13 with 20 mg of 131 
EW diluted in PBS and euthanized for collection of blood and tissue samples. 132 
Serum histamine release 133 
Following the final oral challenge, whole blood was collected by cardiac puncture and two 134 
serum samples were pooled in equal volumes within each group (n=5) due to the limited 135 
volume in individual mouse serum for performing ELISA assays. Histamine concentrations 136 
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were assayed using a commercial ELISA kit (Labor Diagnostika Nord, Nordhon, Germany) 137 
following the manufacturer’s instructions.  138 
Total and specific IgE and IgG in serum 139 
Concentrations of total IgE and IgG in mouse serum were determined by ELISA. In brief, 140 
flat-bottom 96-well microtitre plates (Corning, Costar Corp., MA, USA) were coated with   141 
100 µl of anti-mouse IgE monoclonal antibody (BD Biosciences, San Diego, CA, USA) or 142 
goat anti-mouse IgG (Calbiochem, La Jolla, CA, USA) at 1 µg/ml final concentration. After 143 
overnight incubation at 4°C, the plates were washed with PBS with 0.05% (w/v) Tween-20 144 
(PBST) three times and blocked with 200 µl of 1% (w/v) bovine serum albumin (BSA) in 145 
PBS for 2 hours at 37ºC. The plates were washed with PBST three times and dilutions of 146 
murine IgE (BD) (0.625-20 ng/mL) or IgG standards (AbD Serotec, Raleigh, NC, USA) 147 
(0.625–40 ng/ml) and serum samples (1:50 for IgE and 1:40,000 for IgG) in 1% BSA in 148 
PBST were added (100 µl) to the wells in duplicate and incubated for 2 hours at 37ºC. The 149 
plates were washed further with PBST four times and 100 µL of biotinylated anti-IgE 150 
monoclonal antibody (1:1000) (Caltag, CA, USA) or alkaline phosphate-conjugated goat 151 
anti-mouse IgG (1:2000) (Sigma-Aldrich) were added to the wells and incubated for 1 hour 152 
at 37ºC. After washing four times, 100 µL of avidin-horseradish peroxidise (BD) or 153 
extravidin conjugated to alkaline–phosphatase (1:3000) (Sigma-Aldrich) were added onto 154 
the plates and incubated for 30 min at 37ºC. The reaction product was visualized by adding 155 
100 µL of 3,3′,5,5′-tetra methyl benzidine (TMB, Sigma-Aldrich) or p-nitrophenol 156 
phosphatase (1 mg/ml) (Sigma-Aldrich). The reaction was incubated for 30 min followed 157 
by the addition of 25µl of 0.5 M H2SO4 or 3 N NaOH (stop solution). The optical density 158 
absorbance readings (450 nm or 415 nm) were read using a microplate reader (iMark 159 
Microplate reader, Bio-Rad) and readings obtained from the individual serum samples were 160 
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converted to concentrations of IgE and IgG per millilitre for each assay from the values 161 
obtained from the standard curve.  162 
Specific IgE and IgG levels were measured by coating the plates with 50 µg/ml of the intact 163 
EW, OM or OVA and a similar procedure to that described above was followed. Murine 164 
serum samples were diluted 1:5 for specific IgE and 1:1000 for specific IgG. 165 
Measurement of specific IgG1 and IgG2a activity 166 
Measurements of EW, OM and OVA specific IgG1 and IgG2a in mouse serum samples 167 
were performed by an indirect ELISA. In brief, 96 well microplates (Corning) were coated 168 
with 100 µl of EW or OM (50 µg/ml) and incubated overnight at 4ºC. Plates were washed 169 
three times using PBST and blocked with 200 µl of 1% (w/v) BSA for 1 h at 37ºC. Diluted 170 
serum samples (1:10,000 dilutions for specific IgG1 and 1:1000 for specific IgG2a) were 171 
added to each well and incubated for 1 h at 37ºC. After three washes with PBST, 172 
biotinylated monoclonal rat antibodies were added for IgG1 and IgG2a (100 µl/well; 173 
1µg/ml) (BD) and the plates were incubated for 1 h at 37ºC. The plates were washed three 174 
times and incubated further with 100µl of avidin-HRP peroxidase-conjugated (BD) 175 
(1:2000) for 30 min at 37ºC before detection. The plate was washed six times with PBST 176 
and the reaction was visualized using 50 µl of TMB (Sigma-Aldrich) and incubated for 30 177 
min. The reaction was terminated by adding 25µl of 0.5M H2SO4 and absorbance was read 178 
at 450 nm using a microplate reader (iMark Microplate reader, Bio-Rad). 179 
Measurement of EW-specific IgA in fecal samples 180 
In an effort to further elucidate the underlying mechanism occurring locally at the intestinal 181 
level, mouse fecal pellets were freshly collected on a weekly basis from each mouse group 182 
cage, and were submitted to the following extraction procedure. In brief, fecal pellets were 183 
freeze-dried, diluted 1:7 (w/w) in PBS and homogenized by using a vortex. Samples were 184 
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subsequently centrifuged at 1600 g for 15 min at 4 ºC to remove large fibrous particles. 185 
Supernatants were carefully collected and centrifuged again at 9500 g for 10 min at 4ºC.  186 
Concentrations of EW-specific IgA were determined using a sandwich ELISA procedure. 187 
In brief, flat-bottom 96-well ELISA plates (Corning) were incubated with 100 µl/well of 188 
EW (50µg/well) in 100 mM NaHCO3 (pH 9.6) and stored overnight at 4°C. Plates were 189 
subsequently washed four times PBST, and blocked with 200 µl/well of 1% BSA in PBS 190 
and incubated for 1 h at 37°C. An additional four washes were performed and 100 µl/well 191 
of fecal supernatants were added onto the plate in triplicate wells and incubated overnight 192 
at 4°C. The plates were washed four times with PBST and incubated with 100 µl/well of 193 
biotinylated-monoclonal anti-mouse IgA (1: 500; BD) diluted in 1% BSA in PBST for 1 h 194 
at 37°C. The wells were further washed four times with PBST, and 100 µl/well of avidin- 195 
HRP conjugate (1:2000; BD) were applied onto the plate for 30 min incubation at 37°C. 196 
After a final 4-wash cycle with PBST, EW-specific IgA binding activity was revealed by 197 
addition of 50µl/well of TMB (Sigma-Aldrich). The reaction was terminated after 30 min 198 
by addition of 25µl/well of 0.5 M H2SO4, and absorbance values were determined at 450 199 
nm using an ELISA microplate reader (iMark Microplate reader, Bio-Rad). 200 
Mouse spleen cell cultures and determination of cytokine secretion 201 
At the experimental end-point, post oral challenge, spleen from individual mice was 202 
aseptically removed into ice-cold RPMI-1640 medium (Gibco Invitrogen, New York, NY, 203 
USA), containing NaHCO3 (1.5 g/L), glucose (4.5 g/L), L-glutamine (2mM), sodium 204 
pyruvate (1mM), penicillin (50 U/mL) and streptomycin (50 mg/mL), and two whole 205 
spleens were pooled within each group (n=5/group). The cell suspensions were passed 206 
through a 100 µm nylon membrane cell strainer and transferred to 15 mL conical centrifuge 207 
tubes and centrifuged for 10 min at 500 g at 4ºC. Erythrocytes in spleen cell preparations 208 
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were lysed with 2 mL of red blood cell lysing buffer (Sigma-Aldrich) and 10 mL of RPMI 209 
media was added to stop the lysis. The splenocytes were washed twice with 10 mL RPMI 210 
by centrifugation. Splenocytes were resuspended in 10 mL of medium [RPMI 1640 211 
supplemented with 8% fetal bovine serum (FBS)] (Hyclone, Fisher, Canada) and cell 212 
viability was assessed by trypan blue exclusion. Cells were cultured in 24-well plates 213 
(Corning) at a density of 2.5x106/mL in the absence (negative control wells) or presence of 214 
purified EW (100 µg/mL) in triplicates. Supernatants were collected after 72 h of 215 
incubation in a 5% CO2 humidified incubator and assayed for the presence of cytokines. 216 
Concentrations of IFN-γ, IL-4, TGF-β and IL-10 secreted in murine splenocyte culture 217 
supernatants were assayed by ELISA. Briefly, 96-well plates (Corning) were coated with 218 
100 µL of the capture antibodies: rat anti-mouse IL-4 and INF-γ (BD) (1:250) or rat anti 219 
mouse IL-4 (BD) (1:250) and the plates were incubated at 4ºC overnight. The plates were 220 
washed three times with 200 µL of PBST and blocked with 200 µL of 1% BSA in PBS at 221 
37ºC for 1 h. The plates were further washed three times with PBST and 100 µL of 222 
standard cytokines (BD) at concentrations of 31.250–1000 pg/mL (IFN-γ) or 15.625–5000 223 
pg/mL (IL-4) diluted in 1%  (w/v) BSA in PBST, and the culture supernatant samples were 224 
added  at different dilutions: 1:10 (IFN-γ) or 1:2 (IL-4) and incubated at 37ºC for 2 h. After 225 
washing 4 times 100 µL of detection antibodies were added: biotinylated rat anti-mouse 226 
INF-γ (BD) (1:2000) or biotinylated rat anti-mouse IL-4 (BD) (1:2000) and incubated for 1 227 
h at 37ºC. The plates were washed four times and bound antibodies were detected using 228 
100 µL of HRP-conjugated avidin (BD) at 1:2000 dilution and plates were incubated for 30 229 
min at 37ºC and washed six times with PBST. Then 50 µL of TMB (Sigma-Aldrich) was 230 
used as a substrate and the plate was incubated for 20 min in the dark at 37ºC and 25 µL of 231 
stop solution (0.5 M H2SO4) was added. The optical density was measured by an ELISA 232 
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reader (iMark Microplate reader, Bio-Rad) with a 450 nm filter. Production of TGF-β and 233 
IL-10 in the spleen cell culture supernatants was determined using the ready to use 234 
commercial kit “TGF-B Ready-Set-Go” and “IL-10 Ready-Set-Go” (eBiosciences Inc, San 235 
Diego, CA) following the manufacturer instructions. Standard curves for each cytokine 236 
(15.625–1000 pg/mL TGF-β; 15.625–1000 pg/mL IL-10) were used to quantify the levels 237 
of cytokines present in the culture supernatant samples. 238 
Statistical analysis 239 
Histamine, immunoglobulin and cytokine concentrations measured by ELISA assays were 240 
subjected to ANOVA analyses followed by post hoc multiple-comparison using Tukey’s 241 
test. In all cases, p-values ≤0.05 were considered statistically significant. Statistical 242 
calculations were performed using the GraphPad Prism® package (Graphpad, San Diego, 243 
CA, USA).  244 
 245 
Results and discussion 246 
High in vitro digestibility of HOM’EW 247 
Digestibility of EW and HOM’EW were performed to assess digestibility by using an in 248 
vitro system in two steps, which mimicked digestion in the stomach (gastric) and 249 
duodenum (24). The HOM’EW was more susceptible to digestion than intact EW as shown 250 
in Figure 3 by SDS-PAGE electrophoresis. Looking at the 60 min gastric digests of EW 251 
and HOM´EW (lanes 3 and 6) the band of OVA (44 kDa), the most abundant allergen in 252 
the albumen, is mainly intact in the EW while is almost fully digested in the HOM´EW, 253 
which presented a wide band of digestion products with a molecular mass lower than 10 254 
kDa. The OVT (76 kDa) was fully digested in the gastric phase in both EW and HOM´EW 255 
while the LYS (14.4 kDa) resisted the peptic action as part of the EW but not in the 256 
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HOM´EW. The higher digestibility of the HOM´EW was also keep along duodenal 257 
digestion (lanes 4 and 7) where the profile of HOM´EW is clearer than that of EW since 258 
most of the protein content was completely hydrolyzed. Non-digested EW and 60 min 259 
gastric digests of EW and HOM´EW were further analysed by RP-HPLC (Figure 4) and the 260 
profiles were in agreement with SDS-PAGE outcomes. In the RP-HPLC profile of non-261 
digested EW the main EW allergens were identified such as: OVA that elutes at 55 minutes 262 
and OM after 33 minutes (25) OVT at 46 minutes and LYS at 42 minutes (26) (Figure 4A). 263 
Considerable amount of OVA was present in the EW (Figure 4B) while it was almost 264 
undetectable in the 60 min gastric digest of HOM´EW (Figure 4C). Upon peptic digestion 265 
OM profile displayed a wide non-resolved mix of peaks which were difficult to identify 266 
within the complex matrix of digested EW (Figure 4B). It is interesting to note in the 267 
profile of HOM´EW gastric digest (Figure 4C) the increased amount of peptides from 268 
minutes 15 to 32 compared to that of  the EW gastric digest (Figure 4B), which indicates 269 
the higher degree of hydrolysis in the HOM´EW. This increase in susceptibility to digestion 270 
of HOM’EW can be attributed to the heat treatment because OVA is thermolabile and its 271 
digestibility increases by heat treatment (25, 27). LYS and OVT have also been reported to 272 
be unstable to heat treatment (18). Furthermore OM is reported to be digested into three 273 
fragments and two of them resist duodenal digestion and are able to retain IgE binding 274 
activity (10, 25), hence low concentration of OM in HOM‘EW made it  more susceptible to 275 
digestion. A high stability through digestion is usually accepted as a characteristic nature of 276 
a food allergen which helps to keep the epitopes intact (28), thus the high digestibility of 277 
HOM’EW may be related to the safety of OIT performed in this experiment. The gut 278 
associated lymphoid tissues are wide spread throughout the digestive tract in which the 279 
intestinal lamina propria contains a complex population of cells including activated CD4+ 280 
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T lymphocytes and B lymphocytes, macrophages, dendritic cells, eosinophils and mast 281 
cells. Also there are organized lymphoid tissues, Peyer´s patches being the most prominent, 282 
that likely have a pivotal role in triggering immune responses to digested antigens. 283 
Interestingly it was recently reported that heat treatment of OVA and OM prevented 284 
transport across human intestinal epithelial cells in a form capable of triggering basophil 285 
activation or T-cell activation (29) and together with the advanced degree of digestion of 286 
HOM’EW at intestinal level, compared to intact EW, might be critical in the use of 287 
HOM’EW for successful OIT. We recently reported oral administration of EW 288 
hydrolysates with peptic fragments of <1.4 kDa led to a specific immune 289 
hyporesponsiveness in EW-primed BALB/c mice (30). It was also shown that the higher 290 
the digestibility, the lower the antibody binding and heat treatment showed a significant 291 
influence on the potential allergenicity of the main egg white proteins that could be related 292 
to their resistance to denaturation and digestive enzymes (25). These data put together 293 
strongly supports and augments our study in which the HOM’EW was able to induce 294 
successful tolerance to EW sensitized mice, which may due to tolerogenic peptides present 295 
in HOM’EW. 296 
Low histamine and EW-specific IgE activity post oral challenge.  297 
Histamine concentration was checked in mice sera after oral challenge with EW (Figure 298 
5A). Both treated mouse groups had significantly less histamine than the positive group and 299 
were similar to that of the negative group, which confirmed the success of OIT.  Also EW-300 
specific IgE antibody activity post oral challenge was less in both the treatment groups than 301 
the positive group but significantly higher than negative group. Interestingly, the high dose 302 
group showed higher EW- specific IgE activity than the low dose group (Fig 5B).  303 
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Total and allergen specific IgG and IgG subclasses 304 
Attempting to find other mechanisms that may have contributed to a lower histamine 305 
concentration, we studied in depth sera IgG activity. Total IgG and EW-specific IgG levels 306 
were similar in sensitized mouse groups (data no shown). However, treated mice showed 307 
high OM specific-IgG levels and this increase was significant in the high dose group 308 
(Figure 6A). Antibody to specific IgG1 of EW, OVA and OM were also analyzed without 309 
significant differences between groups, however  EW specific IgG2a was enhanced (data 310 
not shown) and OM and OVA specific IgG2a were significantly higher in the treated 311 
groups (Figure 6B and 6C). The functions of allergen specific IgG have been largely 312 
studied but the roles in immunotherapy are still being investigated and are a point of 313 
discussion. One of the mechanisms related to allergen specific immunotherapy is the 314 
induction of allergen-specific IgG antibodies and it is suggested that these antibodies may 315 
compete with specific IgE to bind the allergen at the mucosal surface and block the allergic 316 
response. On one hand this is questioned because serum concentrations of allergen-specific 317 
IgG are correlating with clinical improvement in some studies but not in others (31), in 318 
addition many mast cells are on the mucosal surfaces and could meet allergens before 319 
antibodies can interpose themselves (32). On the other hand, it has been shown in a series 320 
of interesting experiments how allergen specific IgG can counteract allergen-specific IgE 321 
activity by direct competition by binding epitopes or via inhibitory FcRIIB-dependent 322 
signals (17). On this note in the current study the increase of OVA and OM specific IgG2a 323 
and the increase of OM specific IgG might be effective mechanisms induced during OIT 324 
that contribute to a lower histamine release. 325 
Increased Th1/Th2 ratio  326 
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The role of Th1 and Th2 cell mediated type responses is well established in mouse models 327 
and recent research on T-regulatory cells sheds more light on balance of Th1 and Th2 cell 328 
mediated response. In the present study, analyses of culture supernatants stimulated in vitro 329 
with purified EW indicated that the levels of IFN-γ, the type 1 hallmark cytokine, was 330 
significantly higher in the high dose treated mice (Figure 7A) and no significant difference 331 
was observed in the low dose treatment group as compared to the positive control. With 332 
regards to IL-4 concentration, the Th2 hallmark cytokine, the treatment groups (both high 333 
and low) had significantly less concentration as compared to the positive control group 334 
(Figure 7B). Also concentration of TGF-β (Th3) and IL-10 (Tr1) were analyzed and no 335 
significant difference between groups was observed with TGF-β (Figure 7C), however a 336 
significant increase of IL-10 concentration was found in the high dose treatment group (Fig 337 
7D) indicating a significant role of regulatory T cells in immune modulation caused by OIT 338 
with HOM´EW. 339 
It was of interest to note that the treatment effects was dose dependent and  the high dose 340 
group experienced a marked increase in Th1/Th2 ratio, as a result of a significant increase 341 
of IFN-γ and a significant decrease of IL-4. The switch from Th2 to Th1 response could be 342 
attributed to a significant role of the regulatory cytokine IL-10. It has been reported earlier 343 
in peanut allergic patients undergoing OIT, an increase in IL-10 secretion from peripheral 344 
mononuclear cells during the first months of OIT that eventually tends to go down and 345 
likely depends on the stage of OIT: escalation, build up and maintenance (33). This finding 346 
could be attributed to the low dose group in which dose factor may play a significant role in 347 
OIT. In fact, it has been shown that IL-10 can modulate allergic reactions by different 348 
mechanisms: suppression of allergen-specific IgE, induction of allergen specific 349 
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IgG4/IgG2a, suppression both allergen-specific Th1 and Th2 cells, and reduction of the 350 
release of pro-inflammatory cytokines by mast cells (34-36). The suppression of antigen-351 
specific immune responses by IL-10 is essential in peripheral tolerance to allergens. In mice 352 
it was shown to be the pivotal role of IL-10 in the establishment of peripheral T-cell 353 
tolerance by administration of IL-10, which drove mice to antigen-specific T-cell 354 
unresponsiveness (37, 38). Also Enrique et al., (39) reported high levels of IL-10 in sera 355 
after sublingual immunotherapy in hazelnut allergic patients. Based on our results it may be 356 
postulated that IL-10 has exerted a critical role in immune modulation of high dose 357 
treatment group that might be indicative of a role of T-regulatory cells for induction of oral 358 
tolerance.  359 
EW-specific IgA in fecal samples  360 
EW-specific IgA activity was determined in mouse fecal sample supernatants (Figure 8) in 361 
an effort to further elucidate the mechanisms occurring locally at the intestinal level. Both 362 
the allergic and treatment groups had an increase of EW-specific IgA along the 363 
sensitization phase. Once sensitization phase finished, the positive group experienced a 364 
decrease of EW-specific IgA while treatment groups had an increase of EW-specific IgA at 365 
the beginning of OIT. Then specific EW-IgA activity decreased slowly but was always 366 
higher than the positive group activity. At the end of OIT, treatment groups showed higher 367 
activity of EW-specific IgA than the positive control group. The negative group had low 368 
activity of EW-specific IgA throughout the study. Secretory IgA has an important role in 369 
the immune homeostasis of the gut (16) but its role in food allergy is still unclear. It has 370 
been earlier reported that low levels of allergen-specific IgA in the gut were associated with 371 
development of food allergies (40). Although specific IgA was elevated during the 372 
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sensitization phase, at the end of OIT, just before the end point, we can clearly see how the 373 
treated groups had a high activity of allergen specific IgA while the negative and positive 374 
groups had a low activity of EW-specific IgA suggesting a susceptible state to develop 375 
allergic disease, which supports previous studies (13, 16, 40), and reinforces the fact that a 376 
higher production of EW-specific IgA at the mucosal level may have contributed to the 377 
allergy-suppressive effect of HOM’EW. 378 
In conclusion, the present study established that the success of HOM’EW can be related to 379 
its high digestibility. OIT with a high dose of HOM’EW induced desensitization through a 380 
switch from Th2 to Th1 response marked by an increase in IL-10 concentration. Also less 381 
histamine and EW specific IgE and more specific IgG and IgG2a could have contributed to 382 
suppression of allergic response and high amounts of EW-specific IgA in fecal samples 383 
suggest an important role at the mucosal level that might be contributing to the therapeutic 384 
effect of HOM’EW. 385 
 386 
Abbreviations used 387 
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 513 
Figure captions 514 
 515 
Figure 1. Immunoblot analysis of native OM, egg white (EW) and heated ovomucoid-516 
depleted egg white (HOM`EW) (20µg/well) by using rabbit anti-OM IgG-HRP. Lane 1: 517 
molecular marker; Lane 2: pure OM; Lane 3: EW; Lane 4: HOM`EW. 518 
 519 
Figure 2.Groups of Balb/c mice (n= 40) were orally sensitized twice/week for four weeks 520 
with 5mg of egg white and 10 µg of cholera toxin and desensitized with two different doses 521 
(1 and 2.5 mg) of heated-ovomucoid depleted egg white thrice/week for 6 weeks. Mice 522 
were challenged with 20 mg of intact egg white at the end and blood and tissue samples 523 
were collected for analysis of various parameters.  524 
 525 
Figure 3. SDS-PAGE gel of in vitro gastric digestion at pH 2 (GD) and duodenal digestion 526 
(DD) of egg white (EW) and heated ovomucoid-depleted egg white (HOM`EW) 527 
(40µg/well). Lane 1: molecular marker. Lanes 2-3: GD of EW at 0 and 60 min. Lane 4: DD 528 
of EW at 30 min. Lanes 5-6: GD of HOM`EW at 0 and 60 min. Lanes 7: DD of HOM`EW 529 
at 30 min. 530 
 531 
Figure 4. RP-HPLC analyses of non-digested egg white (EW) (a) and 60 min gastric 532 
digests of EW (b) and heated ovomucoid-depleted egg white (HOM´EW) (c). 533 
 534 
Figure 5.  Serum histamine concentration and egg white-specific IgE activity in mice sera 535 
after oral challenge are represented as mean standard deviation (n = 5) pooled sera. 536 
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Different letters indicate statistically significant differences (P<0.05), between groups of 537 
mice.  538 
 539 
Figure 6. OM-specific IgG, IgG1 and IgG2a activity in mice sera post oral challenge. Data 540 
are represented as mean standard deviation (n = 5 pooled sera). Different letters indicate 541 
statistically significant differences (P<0.05), between groups of mice 542 
 543 
Figure 7. Determination of cytokine concentrations of IFN-γ, IL-4, TGF-β and IL-10 544 
following in vitro stimulation of spleen cell cultures with EW. Data are represented as 545 
mean±standard deviation (n=5 pooled spleens). Different letters indicate statistically 546 
significant differences (P<0.05), between groups of mice. 547 
 548 
Figure 8. Time-course monitoring of egg white (EW)-specific IgA levels in mouse fecal 549 
extracts before and during oral immunotherapy with heated ovomucoid depleted egg white. 550 
Data are represented as mean±SD (n = 3). 551 
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